These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10099129)

  • 21. Monitoring the dynamics of ligand-receptor complexes on model membranes.
    Lata S; Gavutis M; Piehler J
    J Am Chem Soc; 2006 Jan; 128(1):6-7. PubMed ID: 16390094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-hairpin peptidomimetics: design, structures and biological activities.
    Robinson JA
    Acc Chem Res; 2008 Oct; 41(10):1278-88. PubMed ID: 18412373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling.
    He W; Gong K; Smith DK; Ip NY
    FEBS Lett; 2005 Aug; 579(20):4317-23. PubMed ID: 16051226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding the range of cytokines and cytokine receptors in the brain.
    Dantzer R
    Mol Psychiatry; 1996 May; 1(2):98. PubMed ID: 9118331
    [No Abstract]   [Full Text] [Related]  

  • 25. CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation.
    Pahwa R; McCloskey TW; Aroniadis OC; Strbo N; Krishnan S; Pahwa S
    J Infect Dis; 2006 Mar; 193(6):879-87. PubMed ID: 16479523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators.
    Renauld JC
    Nat Rev Immunol; 2003 Aug; 3(8):667-76. PubMed ID: 12974481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel neurohormonal antagonist strategies: vasopressin antagonism, anticytokine therapy, and endothelin antagonism in patients who have heart failure.
    Hedrich O; Finley J; Konstam MA; Udelson JE
    Heart Fail Clin; 2005 Apr; 1(1):103-27. PubMed ID: 17386838
    [No Abstract]   [Full Text] [Related]  

  • 29. Gene expression of cytokines and cytokine receptors is modulated by the common variability of the mitochondrial DNA in cybrid cell lines.
    Bellizzi D; Cavalcante P; Taverna D; Rose G; Passarino G; Salvioli S; Franceschi C; De Benedictis G
    Genes Cells; 2006 Aug; 11(8):883-91. PubMed ID: 16866872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine receptor signalling and aging.
    Fulop T; Larbi A; Douziech N; Levesque I; Varin A; Herbein G
    Mech Ageing Dev; 2006 Jun; 127(6):526-37. PubMed ID: 16530252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer.
    Gillies SD; Lan Y; Brunkhorst B; Wong WK; Li Y; Lo KM
    Cancer Immunol Immunother; 2002 Oct; 51(8):449-60. PubMed ID: 12202906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of factor VIII concentrate on leucocyte cytokine receptor expression in vitro: relevance to inhibitor formation and tolerance induction.
    Hodge G; Saxon B; Revesz T
    Haemophilia; 2006 Mar; 12(2):133-9. PubMed ID: 16476087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new road to neuroinflammation in Parkinson's disease?
    Fuxe KG; Tarakanov AO; Goncharova LB; Agnati LF
    Brain Res Rev; 2008 Aug; 58(2):453-8. PubMed ID: 18457883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice.
    Kang L; McIntyre KW; Gillooly KM; Yang Y; Haycock J; Roberts S; Khanna A; Herpin TF; Yu G; Wu X; Morton GC; Tuerdi H; Koplowitz B; Walker SG; Wardwell-Swanson J; Macor JE; Lawrence RM; Carlson KE
    J Leukoc Biol; 2006 Oct; 80(4):897-904. PubMed ID: 16888084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciliary neurotrophic factor may activate mature astrocytes via binding with the leukemia inhibitory factor receptor.
    Monville C; Coulpier M; Conti L; De-Fraja C; Dreyfus P; Fages C; Riche D; Tardy M; Cattaneo E; Peschanski M
    Mol Cell Neurosci; 2001 Feb; 17(2):373-84. PubMed ID: 11178874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways.
    Haarmann-Stemmann T; Bothe H; Abel J
    Biochem Pharmacol; 2009 Feb; 77(4):508-20. PubMed ID: 18848820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAPPIT: a versatile tool to study cytokine receptor signalling.
    Lemmens I; Lievens S; Tavernier J
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1448-51. PubMed ID: 19021573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A journey in structure-based drug discovery: from designed peptides to protein surface topomimetics as antibiotic and antiangiogenic agents.
    Dings RP; Mayo KH
    Acc Chem Res; 2007 Oct; 40(10):1057-65. PubMed ID: 17661438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural aspects of cytokine/receptor interactions.
    Nicola NA
    Ann N Y Acad Sci; 1995 Sep; 766():253-62. PubMed ID: 7486668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.